Age as a selection factor for the local therapy of breast cancer?
Morrow, M.
Journal of the American College of Surgeons 187(1): 94-95
1998
ISSN/ISBN: 1072-7515 PMID: 9660031 Document Number: 490754
Document emailed within 1 workday
Related Documents
Lüscher, N.J. 1992: Reconstructive measures in local recurrence after breast saving therapy of breast cancer Helvetica Chirurgica Acta 59(1): 181-187Lüscher, N.J.; Tschopp, H.M. 1989: Local late sequelae following breast saving therapy of breast cancer: problem cases and possibilities for their correction Helvetica Chirurgica Acta 55(6): 861-868
Cikes, M.; Pettavel, J. 1977: Selection of patients with breast cancer with regard to endocrine therapy Schweizerische Medizinische Wochenschrift 107(46): 1645-1655
2011: Categorization of triple-negative breast cancer patients will help in targeted therapy selection Oncology 25(9): 849
Cady, B. 2007: Local therapy and survival in breast cancer New England Journal of Medicine 357(10): 1051-1052; Author Reply 1052
Winkfield, K.M.; Harris, J.R. 2009: Effective local therapy and long-term survival in breast cancer Oncology 23(8): 669-675
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Fersis, N.; Smyczek-Gargya, B.; Armeanu, S.; Gagulic, E.; Pantic, L.; Relakis, K.; Friedrich, M.; Wallwiener, D. 2004: Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer European Journal of Gynaecological Oncology 25(1): 45-50
Stula, N. 1992: Adjuvant cytostatic therapy of breast cancer as an important factor in the postponing of a relapse and longer survival period Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 46(2): 101-111
Gebauer, G.; Jäger, W.; Lang, N. 1998: mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells Anticancer Research 18(2a): 1191-1195
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Mayrovitz, H.N.; Yzer, J.A. 2017: Local Skin Cooling as an Aid to the Management of Patients with Breast Cancer Related Lymphedema and Fibrosis of the Arm or Breast Lymphology 50(2): 56-66
Enger, H.; Pettersen, E.H.; Schlichting, E.; Kåresen, R.; Guldvog, I.; Sauer, T. 1998: Breast conserving surgery for breast cancer--local recurrence Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(21): 3262-3265
Yamashita, J.; Ogawa, M.; Beppu, T. 1993: Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines Research Communications in Chemical Pathology and Pharmacology 82(2): 249-252
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Sannella, J.J. 1975: Selection of breast carcinoma patients for endocrine therapy Journal of the Tennessee Medical Association 68(12): 982
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Kaneko, J.; Isogai, J.; Yoshida, T.; Hasegawa, K.; Matsui, T.; Aoyagi, H.; Maejima, S. 2014: A case of hepatic metastases from colorectal cancer in a long-term survivor undergoing local combined modality therapy for repeated local recurrences Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1648-1650